These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1982783)

  • 1. A low CA++ level in effluent as a risk factor for the peritonitis in CAPD patients.
    Suga H; Honda H; Naganuma S; Yashuo M; Suzuki T; Teraoka S; Agishi T; Ota K
    Adv Perit Dial; 1990; 6():102-5. PubMed ID: 1982783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
    Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
    Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and intraperitoneal proinflammatory cytokine profiles in patients on continuous ambulatory peritoneal dialysis.
    Maksic D; Vasilijic S; Colic M; Stankovic-Popovic V; Bokonjic D
    Adv Perit Dial; 2009; 25():50-5. PubMed ID: 19886317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial peritoneal macrophage function studies in CAPD patients with peritonitis.
    Lin CY; Huang TP
    Adv Perit Dial; 1990; 6():114-9. PubMed ID: 1982786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal dialysis fluid (PDF) C++ and 1,25(OH)2D3 modulate peritoneal macrophage (PM0) antimicrobial activity in CAPD patients.
    Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Barocci S; Cantaluppi A; Salit M
    Adv Perit Dial; 1990; 6():110-3. PubMed ID: 1982785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-12 and -18 levels in peritoneal dialysate effluent correlate with the outcome of peritonitis in patients undergoing peritoneal dialysis: implications for the Type I/Type II T-cell immune response.
    Wang HH; Lin CY
    Am J Kidney Dis; 2005 Aug; 46(2):328-38. PubMed ID: 16112053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic and intraperitoneal proinflammatory cytokines profiles in patients on chronic peritoneal dialysis.
    Maksić D; Colić M; Stanković-Popović V; Radojević M; Bokonjić D
    Med Pregl; 2007; 60 Suppl 2():53-7. PubMed ID: 18928158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Ca++ and 1,25(OH)2D3 on peritoneal immune-cell cytokine release and fibroblast proliferation in CAPD patients.
    Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Santoni O; Barocci S; Versace F; Cantaluppi A; Salit M; Lamperi S
    Adv Perit Dial; 1989; 5():111-20. PubMed ID: 2577390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokines and peritonitis in continuous ambulatory peritoneal dialysis: immunodeviation and immunodeficiency.
    Klínger J; Enríquez J; Arturo JA; Delgado M; Avila G; Ceballos O
    Adv Perit Dial; 2002; 18():170-6. PubMed ID: 12402613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial peritonitis and beta-2 microglobulin (B2M) production by peritoneal macrophages (PM0) in CAPD patients.
    Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Canepa M; Zanin T; Cantaluppi A; Salit M
    Adv Perit Dial; 1990; 6():106-9. PubMed ID: 1982784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypokalaemia: an independent risk factor of Enterobacteriaceae peritonitis in CAPD patients.
    Chuang YW; Shu KH; Yu TM; Cheng CH; Chen CH
    Nephrol Dial Transplant; 2009 May; 24(5):1603-8. PubMed ID: 19103738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopolysaccharide binding protein: a marker for intraperitoneal bacterial infection in patients with CAPD peritonitis.
    Schäfer K; Schumann RR; Stöteknuel S; Böhler J; Schollmeyer P; Dobos GJ
    Adv Perit Dial; 1997; 13():210-3. PubMed ID: 9360683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis.
    Montenegro J; Saracho R; Gallardo I; Martínez I; Muñoz R; Quintanilla N
    Nephrol Dial Transplant; 2007 Jun; 22(6):1703-8. PubMed ID: 17405794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal macrophages from patients on CAPD show an increased capacity to secrete interleukin-1 beta during peritonitis.
    Fieren MW; van den Bemd GJ; Bonta IL
    Adv Perit Dial; 1990; 6():120-2. PubMed ID: 1982787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MCP-1 levels are elevated in peritonitis fluid from CAPD patients due to secretion by peritoneal macrophages.
    Sach M; Loetscher P; Burger JA; Knopf HP; Schollmeyer P; Dobos GJ
    Adv Perit Dial; 1995; 11():19-23. PubMed ID: 8534702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritonitis in continuous ambulatory peritoneal dialysis: cytokines in peritoneal fluid and blood.
    Enríquez J; Klínger J; Arturo JA; Delgado M; Tobar C; Mosquera M
    Adv Perit Dial; 2002; 18():177-83. PubMed ID: 12402614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ca++ and 1,25(OH)2D3 enhance peritoneal macrophage (PMPhi) antimicrobial functions in CAPD.
    Carozzi S; Nasini MG; Schelotto C; Caviglia P; Santoni O; Barocci S; Versace F; Cantaluppi A; Salit M; Lamperi S
    Adv Perit Dial; 1989; 5():103-10. PubMed ID: 2577389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Nishina M; Endoh M; Suzuki D; Tanabe R; Endoh H; Hirahara I; Sakai H
    Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study.
    Kim S; Oh J; Kim S; Chung W; Ahn C; Kim SG; Oh KH
    Nephrol Dial Transplant; 2009 Sep; 24(9):2899-908. PubMed ID: 19258384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.